Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN68653575
ISRCTN68653575
Completed
N/A

se of botulinum toxin-A for musculoskeletal pain in patients with whiplash associated disorders

Povisa Medical Center (Povisa Centro Medico) (Spain)0 sites160 target enrollmentFebruary 2, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsWhiplash cervical injuriesInjury, Occupational Diseases, PoisoningInjuries to the neck

Overview

Phase
N/A
Intervention
Not specified
Conditions
Whiplash cervical injuries
Sponsor
Povisa Medical Center (Povisa Centro Medico) (Spain)
Enrollment
160
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Povisa Medical Center (Povisa Centro Medico) (Spain)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with grade II Whiplash Associated Disorders (WAD) of Quebec Task Force (QTF)\-WAD
  • •2\. Neck pain secondary to cervical whiplash injury with musculoskeletal signs of greater than three months
  • •3\. Aged greater than 18 years
  • •4\. Lack of response to conventional physical and medical therapy
  • •Musculoskeletal signs:
  • •1\. Palpable band, spot tenderness, and jump sign in cervical muscles or restricted range of motion in cervical spine
  • •2\. Demonstrated precipitation of neck pain with external pressure over the occipital or cervical region on affected side
  • •3\. Myofascial pain of cervical muscles
  • •4\. Experienced pain on maneuver of stretching
  • •5\. Trigger point with associated referred pain

Exclusion Criteria

  • •1\. Serious somatic or psychiatric illness
  • •2\. Anticoagulation therapy
  • •3\. Myasthenia gravis
  • •4\. Pregnancy or breast\-feeding
  • •5\. Abnormal anatomy
  • •6\. Rheumatoid disease or radiculopathy
  • •7\. Need for regular analgesic for severe pain

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Botulinumtoxin A as a treatment for myalgia and myofacial pain in patient with temporomandibulardisorders – a quality study associated to a new treatment routine.Temporomandibular disorderTherapeutic area: Diseases [C] - Stomatognathic Diseases [C07]Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
CTIS2023-504033-44-00Region Stockholm Folktandvarden1
Active, Not Recruiting
Phase 1
Botulinum toxin-A as a treatment for chronic muscle-related pain in adults with spastic cerebral palsy: a randomized controlled trial.Spastic cerebral palsyTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-000095-10-SEKarolinska Institutet48
Completed
N/A
Analgesic effect of botulinum toxin on muscle pain in temporomandibular disorder patients : A randomized, double-blind, placebo-controlled pilot studyDiseases of the digestive system
KCT0008715Yonsei University Health System, Dental Hospital21
Completed
N/A
The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back PainSubacute Cervical PainSubacute Upper Back Pain
NCT00282958Palo Alto Veterans Institute for Research
Unknown
Phase 2
Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum ToxinTendinopathy Rotator Cuff
NCT02867787Versailles Hospital40